RESPONSIBLE CORPORATIONS IN AN EVER-CHANGING WORLD
Taiho Oncology Europe GmbH strives to make a positive contribution to society and the environment. We support our local communities through charitable endeavors, and we work proactively to protect the environment by minimizing the environmental impact in every aspect of our work – from research and development to production, distribution, marketing, and disposal.
Furthermore, as a member of Otsuka Holdings, we are part of a group of companies that pursues initiatives that are shaped by mutual respect and open communication with all stakeholders, including customers and business partners in the countries and regions where we do business.
MAKING A POSITIVE CONTRIBUTION
“We are proud to support patients through partnerships with organizations that share our company’s mission to improve awareness, prevention and access to quality care for cancer patients and the community at risk.”
SPOTLIGHT ON CHOLANGIOCARCINOMA
Taiho Oncology is proud to be an important part of the progress being made in the treatment of intrahepatic cholangiocarcinoma, a rare and aggressive cancer inside the bile ducts of the liver. Cholangiocarcinoma can also occur outside the bile ducts of the liver (eCCA). As we mark Cholangiocarcinoma Awareness Month, we join patient advocacy groups in enhancing awareness of this disease. We encourage patients, caregivers, family members, and health care professionals to contact the patient advocacy groups listed above for information and resources.
Within our Patient Alliances organization, we strive to understand the patient journey from diagnosis through treatment, incorporating the patient experience into the fabric of the company. We do this by actively engaging with patient advocacy organizations throughout clinical development and post-product launch to ensure we understand patient and caregiver perspectives and insights in the pursuit of advancing care. Additionally, Taiho provides funding support for patient and caregiver programs, initiatives, education and research.
WALKING THE TALK
For the eighth consecutive year, Taiho Oncology served as a national sponsor of the recent 2022 Philadelphia Walk to End Colon Cancer. This walk is one of our major Corporate Engagement events, and Taiho employees helped raise awareness and funds to support the advocacy work of the Colorectal Cancer Alliance.